Tissue-Specific Expression Profiling of Receptor for Advanced Glycation End Products and Its Soluble Forms in Esophageal and Lung Cancer
- 1 June 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Genetic Testing and Molecular Biomarkers
- Vol. 14 (3), 355-361
- https://doi.org/10.1089/gtmb.2009.0064
Abstract
The receptor for advanced glycation end products (RAGE) interacts with several ligands and is involved in various human diseases. Several splicing forms of the RAGE gene have been characterized, and two general mechanisms are usually responsible for the generation of soluble receptors. However, variants distribution and respective roles in different tumors are not clear. We analyzed RAGE and hRAGEsec mRNA expression in esophageal and lung cancer by RT-polymerase chain reaction. The Agilent clipper 1000 Bioanalyzer using lab-on-a-chip technology was applied to size and quantify the polymerase chain reaction products. Western blotting was performed to measure total soluble RAGE protein levels. The results showed that RAGE and its splice variants increased in esophageal cancers and decreased in lung cancers. We conclude that RAGE presents as a major isoform; soluble RAGE may also play certain roles in esophageal cancer and lung cancer.Keywords
This publication has 25 references indexed in Scilit:
- Calcium-regulated intramembrane proteolysis of the RAGE receptorBiochemical and Biophysical Research Communications, 2008
- Identification, classification, and expression ofRAGEgene splice variantsThe FASEB Journal, 2007
- Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinomaHistopathology, 2007
- Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcomaCancer, 2007
- Colon Cancer Cell-Derived High Mobility Group 1/Amphoterin Induces Growth Inhibition and Apoptosis in MacrophagesThe American Journal of Pathology, 2005
- Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinomaCarcinogenesis: Integrative Cancer Research, 2004
- Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cellsMolecular Immunology, 2004
- The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic PlaquesCirculation, 2003
- Dual roles for HMGB1: DNA binding and cytokineInnate Immunity, 2001
- RAGE Mediates a Novel Proinflammatory AxisCell, 1999